Pregabalin, showcased under the brand name Lyrica among others, is a drug used to treat epilepsy, neuropathic torment, fibromyalgia, anxious leg condition, and summed up tension issue. Its utilization in epilepsy is as an extra treatment for halfway seizures. At the point when utilized before medical procedure, it diminishes torment however brings about more prominent sedation and visual aggravations. It is taken by mouth. Common reactions incorporate cerebral pain, dazedness, drowsiness, disarray, issue with memory, helpless coordination, dry mouth, issue with vision, and weight gain. Genuine reactions may incorporate angioedema, medicate abuse, and an expanded self destruction risk. When pregabalin is taken at high dosages over a significant stretch of time, compulsion may happen, yet whenever taken at regular portions the hazard is low. Use during pregnancy or breastfeeding is of indistinct security. Pregabalin is a gabapentinoid and acts by repressing certain calcium channels.It was affirmed for clinical use in the United States in 2004. It was created as a replacement to gabapentin. It is accessible as a nonexclusive medicine in various nations, including the United States starting at 2019.
Awards 2021: International Journal of Neurorehabilitation
Awards 2021: International Journal of Neurorehabilitation
Commentary: International Journal of Neurorehabilitation
Commentary: International Journal of Neurorehabilitation
Commentary: International Journal of Neurorehabilitation
Commentary: International Journal of Neurorehabilitation
Review Article: International Journal of Neurorehabilitation
Review Article: International Journal of Neurorehabilitation
Editorial: International Journal of Neurorehabilitation
Editorial: International Journal of Neurorehabilitation
Keynote: Neurological Disorders
Keynote: Neurological Disorders
Scientific Tracks Abstracts: Neurological Disorders
Scientific Tracks Abstracts: Neurological Disorders
Keynote: Neurological Disorders
Keynote: Neurological Disorders
Posters-Accepted Abstracts: Neurological Disorders
Posters-Accepted Abstracts: Neurological Disorders
Scientific Tracks Abstracts: Neurological Disorders
Scientific Tracks Abstracts: Neurological Disorders
International Journal of Neurorehabilitation received 793 citations as per Google Scholar report